IGI Inc.

Clinical Trial SponsorPrivate Company
New York, New York, United States
2019
Founded
50-200
Employees

About IGI Inc.

At IGI, we strive to fast-track the development of new cancer cures through collaboration. We focus on creating cutting-edge solutions to treat hematological malignancies and solid tumors through collaborations with other institutions including but not limited to other biotech companies, start-ups, investors and academia. We’re pioneering advancements in oncology that enhance the immune system’s ability to detect and kill cancer. Born from our patented BEAT® (Bispecific Engagement by Antibodies based on the T-cell receptor) technology platform, and ISB 2001 (BCMA x CD38 x CD3 trispecific antibody) is in development for patients with multiple myeloma.

Experience & capabilities

Products:Therapeutic products

Browse companies by location

Similar Clinical Trial Sponsor companies in United States

Abbott

Clinical Trial Sponsor
Chicago, United States·>5,000 employees

AbbVie Inc.

Clinical Trial Sponsor
North Chicago, United States·>5,000 employees

AffyImmune Therapeutics, Inc.

Clinical Trial Sponsor
Natick, United States·10-50 employees

AffyImmune is a clinical-stage biotechnology company that optimizes CAR T cells for the treatment of solid tumors using our Tune & Track platform.